(b)(4).This report is being submitted due to a retrospective review conducted under (b)(4).Device by manufacturer: on 15-jun-2015, an fse was dispatched to the customer facility to address the reported event.Fse began to troubleshoot the issue.Fse verified error and replaced defective rheodyne valve, installed new small syringe due to leak, and a new sample needle.Customer had a side vented sample needle that they received from tosoh tech support.Fse replaced tubing from injection valve to large syringe.The g7 controls are within specification and total area is normal.The customer ran quality control (qc) in which all results were within acceptable range and verified that the analyzer was functioning correctly.The g7 analyzer was functioning as intended and the errors cleared.No further action required by field service.The most probable cause of the reported event was due to a defective rheodyne valve.
|
On (b)(6) 2015, a customer reported a defective rheodyne valve with their g7 analyzer.The customer is unable to run hba1c patient samples.A field service engineer (fse) was dispatched to address the reported event, which resulted in delayed reporting hba1c patient results.There was no indication of patient intervention or adverse health consequences due to the delay in reporting.
|